United States Biosimilar Drug Market Report 2017

January 2017 | 117 pages | ID: U1F44FB18C2EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Biosimilar Drug

Revenue, means the sales value of Biosimilar Drug

This report studies sales (consumption) of Biosimilar Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• CP Guojian Pharma
• Biotech Pharma
• Celgen Pharma
• Henlius

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Injection
• Tablets
• Others

Split by applications, this report focuses on sales, market share and growth rate of Biosimilar Drug in each application, can be divided into

• Ankylosing Spondylitis
• Tumor
• Rheumatoid Arthrtis
• Cardiovascular

Contents

United States Biosimilar Drug Market Report 2017

1 BIOSIMILAR DRUG OVERVIEW

1.1 Product Overview and Scope of Biosimilar Drug
1.2 Classification of Biosimilar Drug
  1.2.1 Injection
  1.2.2 Tablets
  1.2.3 Others
1.3 Application of Biosimilar Drug
  1.3.1 Ankylosing Spondylitis
  1.3.2 Tumor
  1.3.3 Rheumatoid Arthrtis
  1.3.4 Cardiovascular
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Biosimilar Drug (2012-2022)
  1.4.1 United States Biosimilar Drug Sales and Growth Rate (2012-2022)
  1.4.2 United States Biosimilar Drug Revenue and Growth Rate (2012-2022)

2 UNITED STATES BIOSIMILAR DRUG COMPETITION BY MANUFACTURERS

2.1 United States Biosimilar Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Biosimilar Drug Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Biosimilar Drug Average Price by Manufactures (2015 and 2016)
2.4 Biosimilar Drug Market Competitive Situation and Trends
  2.4.1 Biosimilar Drug Market Concentration Rate
  2.4.2 Biosimilar Drug Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES BIOSIMILAR DRUG SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Biosimilar Drug Sales and Market Share by States (2012-2017)
3.2 United States Biosimilar Drug Revenue and Market Share by States (2012-2017)
3.3 United States Biosimilar Drug Price by States (2012-2017)

4 UNITED STATES BIOSIMILAR DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Biosimilar Drug Sales and Market Share by Type (2012-2017)
4.2 United States Biosimilar Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Biosimilar Drug Price by Type (2012-2017)
4.4 United States Biosimilar Drug Sales Growth Rate by Type (2012-2017)

5 UNITED STATES BIOSIMILAR DRUG SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Biosimilar Drug Sales and Market Share by Application (2012-2017)
5.2 United States Biosimilar Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES BIOSIMILAR DRUG MANUFACTURERS PROFILES/ANALYSIS

6.1 CP Guojian Pharma
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Biosimilar Drug Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Biotech Pharma
  6.2.2 Biosimilar Drug Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Biotech Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Celgen Pharma
  6.3.2 Biosimilar Drug Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Celgen Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Henlius
  6.4.2 Biosimilar Drug Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Henlius Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview

7 BIOSIMILAR DRUG MANUFACTURING COST ANALYSIS

7.1 Biosimilar Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Biosimilar Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Biosimilar Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES BIOSIMILAR DRUG MARKET FORECAST (2017-2022)

11.1 United States Biosimilar Drug Sales, Revenue Forecast (2017-2022)
11.2 United States Biosimilar Drug Sales Forecast by Type (2017-2022)
11.3 United States Biosimilar Drug Sales Forecast by Application (2017-2022)
11.4 Biosimilar Drug Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Biosimilar Drug
Table Classification of Biosimilar Drug
Figure United States Sales Market Share of Biosimilar Drug by Type in 2015
Figure Injection Picture
Figure Tablets Picture
Figure Others Picture
Table Application of Biosimilar Drug
Figure United States Sales Market Share of Biosimilar Drug by Application in 2015
Figure Ankylosing Spondylitis Examples
Figure Tumor Examples
Figure Rheumatoid Arthrtis Examples
Figure Cardiovascular Examples
Figure United States Biosimilar Drug Sales and Growth Rate (2012-2022)
Figure United States Biosimilar Drug Revenue and Growth Rate (2012-2022)
Table United States Biosimilar Drug Sales of Key Manufacturers (2015 and 2016)
Table United States Biosimilar Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Biosimilar Drug Sales Share by Manufacturers
Figure 2016 Biosimilar Drug Sales Share by Manufacturers
Table United States Biosimilar Drug Revenue by Manufacturers (2015 and 2016)
Table United States Biosimilar Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Biosimilar Drug Revenue Share by Manufacturers
Table 2016 United States Biosimilar Drug Revenue Share by Manufacturers
Table United States Market Biosimilar Drug Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Biosimilar Drug Average Price of Key Manufacturers in 2015
Figure Biosimilar Drug Market Share of Top 3 Manufacturers
Figure Biosimilar Drug Market Share of Top 5 Manufacturers
Table United States Biosimilar Drug Sales by States (2012-2017)
Table United States Biosimilar Drug Sales Share by States (2012-2017)
Figure United States Biosimilar Drug Sales Market Share by States in 2015
Table United States Biosimilar Drug Revenue and Market Share by States (2012-2017)
Table United States Biosimilar Drug Revenue Share by States (2012-2017)
Figure Revenue Market Share of Biosimilar Drug by States (2012-2017)
Table United States Biosimilar Drug Price by States (2012-2017)
Table United States Biosimilar Drug Sales by Type (2012-2017)
Table United States Biosimilar Drug Sales Share by Type (2012-2017)
Figure United States Biosimilar Drug Sales Market Share by Type in 2015
Table United States Biosimilar Drug Revenue and Market Share by Type (2012-2017)
Table United States Biosimilar Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biosimilar Drug by Type (2012-2017)
Table United States Biosimilar Drug Price by Type (2012-2017)
Figure United States Biosimilar Drug Sales Growth Rate by Type (2012-2017)
Table United States Biosimilar Drug Sales by Application (2012-2017)
Table United States Biosimilar Drug Sales Market Share by Application (2012-2017)
Figure United States Biosimilar Drug Sales Market Share by Application in 2015
Table United States Biosimilar Drug Sales Growth Rate by Application (2012-2017)
Figure United States Biosimilar Drug Sales Growth Rate by Application (2012-2017)
Table CP Guojian Pharma Basic Information List
Table CP Guojian Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure CP Guojian Pharma Biosimilar Drug Sales Market Share (2012-2017)
Table Biotech Pharma Basic Information List
Table Biotech Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Biotech Pharma Biosimilar Drug Sales Market Share (2012-2017)
Table Celgen Pharma Basic Information List
Table Celgen Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Celgen Pharma Biosimilar Drug Sales Market Share (2012-2017)
Table Henlius Basic Information List
Table Henlius Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Henlius Biosimilar Drug Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar Drug
Figure Manufacturing Process Analysis of Biosimilar Drug
Figure Biosimilar Drug Industrial Chain Analysis
Table Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2015
Table Major Buyers of Biosimilar Drug
Table Distributors/Traders List
Figure United States Biosimilar Drug Production and Growth Rate Forecast (2017-2022)
Figure United States Biosimilar Drug Revenue and Growth Rate Forecast (2017-2022)
Table United States Biosimilar Drug Production Forecast by Type (2017-2022)
Table United States Biosimilar Drug Consumption Forecast by Application (2017-2022)
Table United States Biosimilar Drug Sales Forecast by States (2017-2022)
Table United States Biosimilar Drug Sales Share Forecast by States (2017-2022)